Literature DB >> 9604601

Malaria prevalence and outcome in the in-patients of the Paediatric Department of the State Specialists Hospital (SSH), Maiduguri, Nigeria.

S Gellert1, B Y Hassan, S Meleh, G Hiesgen.   

Abstract

Of 4651 admissions between February 1995 and February 1996, 1043 had a presumed diagnosis of malaria. Six hundred and twenty-seven cases were confirmed by thick blood film examinations. The highest prevalence was in October (124/480 admissions) and the lowest in March (12/303). Sixty-five children died while 562 survived, 12 with defects. The first treatment in 422 children was chloroquine, in 143 quinine, in 59 halofantrin, and in three pyrimethamine with sulfadoxine (Fansidar). 23/422 patients started on chloroquine were switched to halofantrine, two to quinine. A higher mortality was associated with coma, convulsions, hepatosplenomegaly, pulmonary congestion, jaundice, haemoglobinuria, bladder paralysis, anuria. Anaemia and fever were more severe and hypoglycaemia more frequent in children who died than in children who survived (packed cell volume 18.5 +/- 7.1 per cent vs. 25.6 +/- 7.6 per cent, p < 0.001; temperature 39 +/- 1.1 degrees C vs. 38.7 +/- 0.9 degrees C, p < 0.05; random blood sugar < 40 mg/100 ml; 76 vs. 22 per cent, p < 0.01). There was no difference in the median age, pretreatment duration, and prevalence of diarrhoea and sickle cell disease. The male to female ratio was 1.5:1 in the surviving children vs. 1:1.03 in the dead.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9604601     DOI: 10.1093/tropej/44.2.109

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  4 in total

1.  Malaria as a cause of morbidity and mortality in children with homozygous sickle cell disease on the coast of Kenya.

Authors:  Albert N Komba; Julie Makani; Manish Sadarangani; Tolu Ajala-Agbo; James A Berkley; Charles R J C Newton; Kevin Marsh; Thomas N Williams
Journal:  Clin Infect Dis       Date:  2009-07-15       Impact factor: 9.079

2.  The impact of delayed treatment of uncomplicated P. falciparum malaria on progression to severe malaria: A systematic review and a pooled multicentre individual-patient meta-analysis.

Authors:  Andria Mousa; Abdullah Al-Taiar; Nicholas M Anstey; Cyril Badaut; Bridget E Barber; Quique Bassat; Joseph D Challenger; Aubrey J Cunnington; Dibyadyuti Datta; Chris Drakeley; Azra C Ghani; Victor R Gordeuk; Matthew J Grigg; Pierre Hugo; Chandy C John; Alfredo Mayor; Florence Migot-Nabias; Robert O Opoka; Geoffrey Pasvol; Claire Rees; Hugh Reyburn; Eleanor M Riley; Binal N Shah; Antonio Sitoe; Colin J Sutherland; Philip E Thuma; Stefan A Unger; Firmine Viwami; Michael Walther; Christopher J M Whitty; Timothy William; Lucy C Okell
Journal:  PLoS Med       Date:  2020-10-19       Impact factor: 11.069

3.  Haemoglobinuria among children with severe malaria attending tertiary care in Ibadan, Nigeria.

Authors:  Wasiu A Ajetunmobi; Adebola E Orimadegun; Biobele J Brown; Nathaniel K Afolabi; Folorunso A Olabiyi; John I Anetor; Samuel Omokhodion; Kikelomo Osinusi; Felix O Akinbami; Wuraola A Shokunbi; Olugbemiro Sodeinde; Delmiro Fernandez-Reyes
Journal:  Malar J       Date:  2012-10-05       Impact factor: 2.979

4.  A simple method for defining malaria seasonality.

Authors:  Arantxa Roca-Feltrer; Joanna R M Armstrong Schellenberg; Lucy Smith; Ilona Carneiro
Journal:  Malar J       Date:  2009-12-03       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.